GSK and Pfizer to divest ThermaCare brand

15 July 2019 - Deborah Wilkes


The European Commission has given the go-ahead to GlaxoSmithKline's (GSK's) proposed consumer healthcare joint venture with Pfizer, provided the ThermaCare pain-management brand is divested.

Click tags below for more information on topics:

GlaxoSmithKline Pfizer

Annual Subscription Holder?

Sign in to continue reading.

Sign In

Back to Industry News

Share this page: